Cardio Diagnostics Holdings, Inc.CDIOEarnings & Financial Report
Nasdaq · Health Care · In Vitro & In Vivo Diagnostic Substances
Cardio Diagnostics Holdings, Inc. is a precision cardiovascular healthcare company that develops and commercializes integrated genetic and epigenetic diagnostic tests for early detection of coronary heart disease, heart failure, and other cardiovascular conditions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, focusing on delivering accessible, personalized cardiovascular care solutions.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Meeshanthini Dogan | 20.90% | 2.5K | — | 2023-06-28 |
| Robert Philibert | 19.10% | 278.4K | — | 2023-06-28 |
| BlackRock, Inc. | 4.90% | 1.1M | ▼ -0.30pp | 2024-05-08 |